Health Communication Services

Unblinding Communications

Inform trial participants about their individual treatment assignment to build trust through transparency.

We create, populate, and provide unblinding communications to trial sites for distribution to participants.

Unblinding Communications provide trial participants with:

  • Individual treatment assignment
  • General information about the study, such as study identifiers and start and end dates
  • Educational information about blinding and why it is used in trials
Work With Us

Build Trust Through Personalized Information for Patients

In a CISCRP survey, only 24% of respondents reported whether they received the trial drug or a placebo in their trial, yet 65% of these respondents indicated that this information would be very helpful.1

Fulfill another critically important unmet need by letting each trial participant know of their treatment assignment(s) once the trial is completed. Develop a study-specific template or a globally applicable standardized approach that enables study teams to easily implement this communication and build trust with your patient population.

12023 Perceptions and Insights Study, n=4,558

Let's Work Together